Protagonist Therapeutics ... (PTGX)
NASDAQ: PTGX
· Real-Time Price · USD
56.04
1.05 (1.91%)
At close: Aug 15, 2025, 3:59 PM
56.07
0.05%
After-hours: Aug 15, 2025, 04:34 PM EDT
Protagonist Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -34.77M | -11.65M | 131.67M | -33.21M | -30.62M | 207.34M | 27.34M | -34.1M | -38.46M | -33.73M | -34.19M | -31.23M | -41.04M | -20.93M | -36.91M | -33.8M | -30.84M | -24M |
Depreciation & Amortization | 304K | 239K | 536K | 647K | 892K | 820K | 832K | 827K | 821K | 832K | 840K | 853K | 843K | 833K | 819K | 704K | 628K | 624K |
Stock-Based Compensation | 10.91M | 13.8M | 9.09M | 10.16M | 8.94M | 9.35M | 6.6M | 6.76M | 8.34M | 7.58M | 5.51M | 5.95M | 6.8M | 5.93M | 5.02M | 4.78M | 3.94M | 2.66M |
Other Working Capital | 18.72M | -18.72M | -1.29M | -2.32M | -8.73M | 43.89M | -15.86M | 4.07M | 3.47M | -8.36M | -1.8M | -3.99M | 25.4M | -29.42M | 2.72M | 6.51M | -3.11M | -8.05M |
Other Non-Cash Items | 119.47M | n/a | -2.76M | -2.84M | -290.73M | 296.6M | -1.35M | 5.8M | -960K | -1.06M | -914K | -89K | 96K | 358K | 509K | 500K | 473K | 348K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 6.8M | -6.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -124.69M | 124.69M | -167.72M | -2.63M | 291.06M | -243.33M | -16.46M | 908K | 4.02M | -7.98M | -2.88M | -683K | 19.66M | -23.86M | 3.62M | -645K | 2.1M | -8.39M |
Operating Cash Flow | -28.78M | 125.36M | -29.18M | -27.86M | 268.62M | -27.43M | 16.96M | -26.61M | -26.24M | -34.35M | -31.64M | -25.2M | -13.63M | -37.67M | -26.94M | -28.47M | -23.7M | -28.76M |
Capital Expenditures | -813K | -545K | -310K | -775K | -28K | -242K | -19K | -404K | -176K | -10K | -70K | -162K | -290K | -273K | -196K | -265K | -500K | -140K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 61.27M | 13.15M | -25.94M | -9.84M | -4M | -57.44M | -35.02M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -67.15M | -214.04M | -114.41M | -266.67M | -174.96M | -65.67M | -97.97M | -58.95M | -6.06M | -28.06M | -80.59M | -32.16M | -46.29M | -55.83M | -30.69M | -92.44M | -76.25M | -87.2M |
Sales Maturities Of Investments | 122.78M | 120.18M | 105.99M | 58.73M | 86.86M | 71.98M | 36.7M | 45.8M | 32M | 37.9M | 84.6M | 89.59M | 81.31M | 51.63M | 58.75M | 48M | 84.53M | 80.55M |
Other Investing Acitivies | -5K | n/a | n/a | n/a | -88.09M | 6.31M | -61.27M | -13.15M | 25.94M | 9.84M | 4M | 57.44M | 35.02M | -4.2M | 28.06M | -44.44M | 8.27M | -6.65M |
Investing Cash Flow | 54.81M | -94.4M | -8.72M | -208.71M | -88.12M | 6.07M | -61.29M | -13.56M | 25.76M | 9.83M | 3.94M | 57.27M | 34.73M | -4.48M | 27.87M | -44.71M | 7.77M | -6.79M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | 600K | n/a | -600K | n/a | n/a | n/a | n/a | n/a | -2K | n/a | n/a | n/a | n/a | n/a | -189K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.92M | 11.44M | 4.03M | 12.05M | 2.57M | 7.2M | 519K | 35.31M | 304K | 2.16M | 553K | 680K | 680K | 2.37M | 2.17M | 1.38M | 1.4M | 979K |
Financial Cash Flow | 2.92M | 11.44M | 4.03M | 12.05M | 2.57M | 7.2M | 527K | 35.31M | 108.17M | 26.46M | 553K | 680K | 680K | 16.93M | 2.17M | 1.38M | 125.39M | 979K |
Net Cash Flow | 28.95M | 42.4M | -33.87M | -224.52M | 183.07M | -14.16M | -43.8M | -4.86M | 107.7M | 1.94M | -27.07M | 32.58M | 21.76M | -25.19M | 3.12M | -71.87M | 109.41M | -34.59M |
Free Cash Flow | -29.59M | 124.82M | -29.49M | -28.64M | 268.59M | -27.67M | 16.94M | -27.02M | -26.41M | -34.36M | -31.7M | -25.36M | -13.93M | -37.94M | -27.14M | -28.73M | -24.2M | -28.9M |